ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a major focus on Alzheimer’s Disease (AD). We are currently preparing for clinical trials in Europe and in the US. Furthermore, ADvantage is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter.Our work suggests that our lead therapeutic (AD04™) regulates the immune system to provide patie...
ADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a major focus on Alzheimer’s Disease (AD). We are currently preparing for clinical trials in Europe and in the US. Furthermore, ADvantage is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter.Our work suggests that our lead therapeutic (AD04™) regulates the immune system to provide patients with a unique positive effect on the course of Alzheimer’s Disease pathology.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.